Larimar Therapeutics Stock (NASDAQ: LRMR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 100.00 / 581.74K |
Day Range | - - - |
52 Wk Range | 2.18 - 13.68 |
Market Cap | $602.93M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 6.92% |
Days to Cover | 2.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.
Other companies in Larimar Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG) and Pharming (NASDAQ:PHAR).
There is no analysis for Larimar Therapeutics.
Larimar Therapeutics has a consensus price target of $19.50.
The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $9.45 last updated July 19, 2024 at 6:11 PM EDT.
There are no upcoming dividends for Larimar Therapeutics.
Larimar Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Larimar Therapeutics.
Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.